OPKO Health to Report Second Quarter 2025 Financial Results on July 31
Rhea-AI Summary
OPKO Health (NASDAQ:OPK) has scheduled its Second Quarter 2025 financial results announcement for July 31, 2025, after U.S. market close. The company will host a conference call and webcast at 4:30 p.m. Eastern time to discuss operating and financial results for the three and six months ended June 30, 2025.
Participants can pre-register for the call through a provided link, or join by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A replay will be available until August 7, 2025, accessible via phone or webcast.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, OPK declined 2.14%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
MIAMI, July 24, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on Thursday, July 31, 2025. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on July 31 beginning at 4:30 p.m. Eastern time.
CONFERENCE CALL & WEBCAST INFORMATION
OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed at OPKO’s Investor Relations page and here.
A telephone replay will be available until August 7, 2025, by dialing 877-344-7529 (U.S.) or 412-317-0088 (International) and providing the passcode 3096711. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com
FAQ
When will OPKO Health (OPK) release Q2 2025 earnings?
What time is OPKO Health's Q2 2025 earnings call?
How can I join OPKO Health's Q2 2025 earnings call?
How long will OPKO Health's Q2 2025 earnings call replay be available?
